Clinical Trial Update: Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled trial evaluating the safety and efficacy of ritlecitinib in patients with celiac disease in remission; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Ritlecitinib (ritlecitinib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED